Skip to content

Prospective observational study of cord blood transplantation in NJHSG

Prospective observational study of cord blood transplantation in NJHSG - NJHSG-CBT18

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032036
Enrollment
65
Registered
2018-05-07
Start date
2018-07-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute leukemia, Myelodysplastic syndrome, Malignant lymphoma

Interventions

None listed

Sponsors

NJHSG
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who have hematologic malignancies as defined at least one of the following: a) Acute Leukemia b) MDS/MPD c) Lymphoma, CR or chemosensitive PR 2.Age: over 20 years old. 3.Patients who have cord blood with following criteria a) Disclosed in Cord Blood Banks in Japan b) HLA, more than 4/6 matched c) NCC, more than 2.0X107/kg d) no DSA. 4.Patients who give written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients who are not eligible for this study at the discretion of the investigator.

Design outcomes

Primary

MeasureTime frame
The incidence of grade III-IV acute GVHD at 100 days

Countries

Japan

Contacts

Public ContactSouichi Shiratori

Hokkaido university hospital Department of hematology

s.shiratori@med.hokudai.ac.jp011-706-7214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026